Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Acerta Pharma B.V.

Headquarters: Oss, Netherlands
Year Founded: 2012
Status: Private

BioCentury | Nov 4, 2024
Distillery Therapeutics

Inhibiting BTK or CD84 for alcohol-associated hepatitis

BioCentury | Sep 29, 2022
Management Tracks

Kevin Bunker promoted to CSO at Zentalis

Plus Fonck becomes partner at Pureos, and updates from 4D Molecular, Gandeeva, Code and more
BioCentury | Feb 8, 2022
Management Tracks

Lander resigns as Biden’s science adviser

Plus CMO Michaels out at Editas and updates from Tmunity, StrideBio, Adverum, iOmx, Curie and more
BioCentury | Jan 25, 2022
Management Tracks

Braunstein now CMO at Idorsia

Plus Kush, Haddach join RayzeBio and updates from Coherus, InterVenn, AsherBio and more
BioCentury | Jan 8, 2021
Finance

More strategics pile into Dutch early-stage investor BGV’s largest-ever fund

€140 million fourth fund gains new strategic backers Lilly, Novo Ventures
BioCentury | Sep 23, 2020
Management Tracks

Gilead BD head Bender takes top job at pediatric cancer start-up Day One

Bowers to head commercial as Canaan-incubated biotech builds out team  
BioCentury | Jun 24, 2020
Finance

Expect more company creation by BGV with its €105M fourth fund

Dutch VC BioGeneration Ventures expects to create half of the European start-ups backed by new fund
Items per page:
1 - 10 of 38